Implanted Sensors

Turner, Anthony; Gifford, Raeann

doi:10.1007/5346_2012_37

Cited by 3 publications

(2 citation statements)

References 82 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, it was not until 2005 that people with diabetes could purchase these devices for personal use. 14 Medtronic (USA) was the first company to sell a sensor for continuous glucose monitoring and this was marketed as the Guardiant. The sensor is self-implanted in the abdomen and uses classical amperometric detection of hydrogen peroxide, produced as a result of the oxidation of glucose catalysed by GO x .…”

Section: Implantable Biosensors and Non-invasive Monitoringmentioning

confidence: 99%

Biosensors: sense and sensibility

2013

Self Cite

View full text Add to dashboard Cite

This review is based on the Theophilus Redwood Medal and Award lectures, delivered to Royal Society of Chemistry meetings in the UK and Ireland in 2012, and presents a personal overview of the field of biosensors. The biosensors industry is now worth billions of United States dollars, the topic attracts the attention of national initiatives across the world and tens of thousands of papers have been published in the area. This plethora of information is condensed into a concise account of the key achievements to date. The reasons for success are examined, some of the more exciting emerging technologies are highlighted and the author speculates on the importance of biosensors as a ubiquitous technology of the future for health and the maintenance of wellbeing.

show abstract

Section: Implantable Biosensors and Non-invasive Monitoringmentioning

confidence: 99%

Biosensors: sense and sensibility

2013

Self Cite

View full text Add to dashboard Cite

show abstract

“…Monitoring of glucose in blood (glycemia) is central for control of diabetes mellitus, which affects 2% of the world population and 6% of adult population in the western world, and is the most representative biosensing target involving 85% of the biosensing market. 31,32 The ability to modify a core design, without extensive knowledge of CAD operation, is a bonus for biosensor developers whose focus is beyond microfabrication. With the 3D printer the exposure patterns are bitmap images that can be edited with image retouching software.…”

mentioning

confidence: 99%

Low cost lab-on-a-chip prototyping with a consumer grade 3D printer

2014

View full text Add to dashboard Cite

show abstract

Point of Care diagnostics - Using Nanomaterials as detection probes

Yadav,

Vaishnav,

Verma

et al. 2023

RJPT

View full text Add to dashboard Cite

Point of care diagnostics (POCD) are becoming an integral part in modern health care system. It helps enormously in diagnosis and monitoring of any illness. These diagnostics help to provide rapid and fast results at a low cost. POCD has an idea to develop such portable devices, chips, system using nanomaterials as detection-based sensors for quantifying different analytes in complex samples. Incorporating nano based structures in POCD makes it highly sensitive and a easy and fast detecting tool for future generation. Nanomaterials of various size and shape are prepared and due to their unique sensing properties, they help in signal generation and quantification of analyte become easy. In this review we aimed to focus on the types of point of care diagnostics made using nanomaterials, which can be a greatest tool in identification of analytes in future world.

show abstract

Implanted Sensors

Cited by 3 publications

References 82 publications

Biosensors: sense and sensibility

Biosensors: sense and sensibility

Low cost lab-on-a-chip prototyping with a consumer grade 3D printer

Point of Care diagnostics - Using Nanomaterials as detection probes

Contact Info

Product

Resources

About